Fundraising Fox

Phase Genomics

Seattle, US · Founded 2015 · Delaware corporation · 3 known investors

phasegenomics.com ↗

Phase Genomics develops ultra-long-range genome sequencing technology and computational tools for analyzing genetic data in research, medicine, and agriculture. The platform enables scientists to identify chromosomal abnormalities, analyze complex microbial samples, construct reference genomes, and study genetic interactions.

AI & Machine LearningBiotechDeep Techin /phase-genomics-inc@phasegenomics

Founders & leadership

IL
Ivan LiachkoExecutive Officer, Director, Promoter
SS
Shawn SullivanExecutive Officer, Promoter

Investors · 3

Congruent VenturesSan Francisco · $100K – $5M
Hemi Ventures, LlcPalo Alto · $250K – $500Kvia Amy Gu · inferred
Alliance of AngelsreportedSeattle

Reported raises · per SEC filings

Form D private placements
▶$4.8MraisedMar 2023 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shawn SullivanExecutive Officer, Promoter
  • Ivan LiachkoExecutive Officer, Director, Promoter
  • Kayla YoungExecutive Officer
Offering amount
$6.6M
Amount sold
$4.8M
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedNov 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ivan LiachkoExecutive Officer, Director, Promoter
  • Shawn SullivanExecutive Officer, Promoter
Offering amount
$1.4M
Amount sold
$1M
First sale
Nov 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news